ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $286,000 | -34.3% | 4,309 | -38.2% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | -55.8% | 6,967 | -41.4% | 0.00% | -50.0% |
| Q2 2021 | $984,000 | +42.4% | 11,882 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $691,000 | -24.8% | 10,425 | -13.0% | 0.00% | 0.0% |
| Q4 2020 | $919,000 | +184.5% | 11,982 | +59.8% | 0.00% | +100.0% |
| Q3 2020 | $323,000 | -50.5% | 7,499 | -50.4% | 0.00% | -50.0% |
| Q2 2020 | $653,000 | -66.6% | 15,127 | -77.7% | 0.00% | -81.8% |
| Q1 2020 | $1,954,000 | -78.6% | 67,923 | -52.9% | 0.01% | -76.6% |
| Q4 2019 | $9,138,000 | +86.0% | 144,067 | -17.4% | 0.05% | +56.7% |
| Q3 2019 | $4,914,000 | – | 174,380 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |